(1)要約四半期連結財政状態計算書

(単位:百万円)

 

 

前連結会計年度
(2024年3月31日)

 

当第3四半期連結会計期間
(2024年12月31日)

資産

 

 

 

 

流動資産

 

 

 

 

現金及び現金同等物

 

217,449

 

258,301

営業債権及びその他の債権

 

620,022

 

568,873

その他の金融資産

 

31,338

 

47,353

棚卸資産

 

709,637

 

708,545

その他の流動資産

 

79,077

 

71,017

小計

 

1,657,523

 

1,654,089

売却目的で保有する資産

 

18,359

 

71,623

流動資産合計

 

1,675,882

 

1,725,712

非流動資産

 

 

 

 

有形固定資産

 

796,526

 

796,654

のれん

 

263,757

 

271,328

無形資産

 

272,921

 

262,930

持分法で会計処理されている
投資

 

319,988

 

282,582

その他の金融資産

 

412,747

 

219,280

退職給付に係る資産

 

110,390

 

105,086

繰延税金資産

 

37,070

 

40,563

その他の非流動資産

 

45,537

 

35,342

非流動資産合計

 

2,258,936

 

2,013,765

資産合計

 

3,934,818

 

3,739,477

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

前連結会計年度
(2024年3月31日)

 

当第3四半期連結会計期間
(2024年12月31日)

負債及び資本

 

 

 

 

負債

 

 

 

 

流動負債

 

 

 

 

社債及び借入金

 

585,905

 

539,603

営業債務及びその他の債務

 

543,384

 

525,651

その他の金融負債

 

77,610

 

85,269

未払法人所得税等

 

8,545

 

28,114

引当金

 

90,919

 

102,122

その他の流動負債

 

129,087

 

98,188

小計

 

1,435,450

 

1,378,947

売却目的で保有する資産に
直接関連する負債

 

8,037

 

16,633

流動負債合計

 

1,443,487

 

1,395,580

非流動負債

 

 

 

 

社債及び借入金

 

977,581

 

904,100

その他の金融負債

 

100,144

 

96,132

退職給付に係る負債

 

30,589

 

28,089

引当金

 

46,059

 

25,958

繰延税金負債

 

121,146

 

99,245

その他の非流動負債

 

51,446

 

37,606

非流動負債合計

 

1,326,965

 

1,191,130

負債合計

 

2,770,452

 

2,586,710

資本

 

 

 

 

資本金

 

89,938

 

90,059

資本剰余金

 

237

 

51

利益剰余金

 

578,175

 

635,283

自己株式

 

8,355

 

8,359

その他の資本の構成要素

 

304,033

 

225,047

売却目的で保有する資産に関連する
その他の包括利益

 

1,725

 

5,813

親会社の所有者に帰属する持分
合計

 

965,753

 

947,894

非支配持分

 

198,613

 

204,873

資本合計

 

1,164,366

 

1,152,767

負債及び資本合計

 

3,934,818

 

3,739,477

 

 

 

 

 

 

 

E00752 40050 住友化学株式会社 SUMITOMO CHEMICAL COMPANY, LIMITED 四半期第3号参考様式 [IFRS](連結) IFRS true cte 2024-04-01 2024-12-31 Q3 2025-03-31 2023-04-01 2023-12-31 2024-03-31 1 false false false 40050 2025-02-03 40050 2024-12-31 40050 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-04-01 2024-12-31 40050 2024-04-01 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2024-04-01 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:ReconcilingItemsMember 40050 2024-04-01 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:ReportableSegmentsMember 40050 2024-04-01 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember 40050 2023-12-31 40050 2023-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2023-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2023-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2023-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2023-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2023-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2023-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2023-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2023-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2023-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2023-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2023-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-03-31 40050 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-03-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2023-04-01 2023-12-31 40050 2023-04-01 2023-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2023-04-01 2023-12-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2023-04-01 2023-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2023-04-01 2023-12-31 jpcrp_cor:ReconcilingItemsMember 40050 2023-04-01 2023-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2023-04-01 2023-12-31 jpcrp_cor:ReportableSegmentsMember 40050 2023-04-01 2023-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2023-04-01 2023-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2023-04-01 2023-12-31 tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember 40050 2023-03-31 40050 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2023-03-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure